121.
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
by Wijnans, Leonoor
Vaccine, 2012, Vol.31 (8), p.1246-1254

122.
Influenza vaccine: The challenge of antigenic drift
by Carrat, F
Vaccine, 2007, Vol.25 (39), p.6852-6862

124.
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
by Guy, Bruno
Vaccine, 2009, Vol.28 (3), p.632-649

125.
Comparison of the safety and immunogenicity of an MF59® -adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
by Frey, Sharon E
Vaccine, 2014, Vol.32 (39), p.5027-5034

126.
Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination
by Massin, Sophie
Vaccine, 2014, Vol.33 (5), p.610-614

127.
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials
by Boge, Thierry
Vaccine, 2009, Vol.27 (41), p.5677-5684

128.
Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
by Grode, Leander
Vaccine, 2012, Vol.31 (9), p.1340-1348

129.

130.
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects
by Wigle, Jannah
Vaccine, 2013, Vol.31 (37), p.3811-3817

132.

133.
Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
by Nunes, Julia K
Vaccine, 2014, Vol.32 (43), p.5531-5539

134.

135.
Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS)
by Murtaugh, Michael P
Vaccine, 2011, Vol.29 (46), p.8192-8204

136.
Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005–2009
by Kang, Gagandeep
Vaccine, 2013, Vol.31 (27), p.2879-2883

138.
A combined measure of tuberculous lesions for assessing the efficacy of vaccination against tuberculosis (Mycobacterium bovis) in European badgers (Meles meles) supports the 3Rs pr...
by Birch, Colin P.D
Vaccine, 2021-03-12, Vol.39 (11), p.1661-1666

139.
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
by Holst, Johan
Vaccine, 2009, Vol.27, p.B3-B12

140.
Vaccine review: “ Staphyloccocus aureus vaccines: Problems and prospects”
by Jansen, Kathrin U
Vaccine, 2013, Vol.31 (25), p.2723-2730
